2024-09-16 15:56:18
As the winter season approaches, the Ministry of Labor, Health and Solidarity is mobilizing with all its partners and health professionals to protect infants from the respiratory syncytial virus (RSV), the main virus causing bronchiolitis. With the “Bronchiolitis, I avoid it” program, the public authorities are raising awareness among parents about existing prevention methods, simple actions and preventive treatments, in order to protect their baby against this winter virus.
Acute bronchiolitis in infants is a respiratory disease caused in particular by the respiratory syncytial virus (RSV). It affects the small bronchi of infants and is characterized by respiratory discomfort, the signs of which are coughing and rapid, wheezing breathing. Each winter, during the epidemic season from October to March, it affects approximately 30% of children under two years of age. Although it is mostly benign, bronchiolitis can cause serious complications in infants and remains one of the leading causes of hospitalization of children under one year of age during the winter season.
The prevention of bronchiolitis is, this year again, an essential public health priority. Thanks to a robust prevention strategy, health authorities are increasing parents’ awareness of the causes, symptoms and contagiousness of this infection, and informing them of the simple actions and preventive measures available to protect themselves against it.
Simple actions to take every day to protect little ones
By carrying out daily simple preventive measures, Parents and those around them take action to limit the transmission of RSV and thus prevent bronchiolitis in young children:
Wash your hands before and after each change, feeding, meal or cuddle; Ventilate the entire home regularly; Wear a mask if you have a cold, cough or fever; Avoid taking your child to confined public places, such as supermarkets, restaurants and public transport; Do not share bottles, pacifiers or unwashed cutlery; Do not smoke near babies and children.
The prevention campaign is being strengthened: effective preventive treatments against bronchiolitis
Maternal vaccination and infant immunization with monoclonal antibodies are two alternative strategies.
Vaccination with Abrysvo® vaccine allows parents to choose a strategy that relies on an injection to the mother during her pregnancy, and not to the newborn. This vaccination solution thus completes the range of preventive treatments that were already available. Injected between the end of the seventh month and the end of the eighth month of pregnancy, the Abrysvo® vaccine allows the pregnant woman to produce antibodies that she transmits to her child through the placenta. Thanks to this vaccination of the mother, the infant is thus protected from birth and up to the age of 6 months against RSV.
The two preventive treatments, Synagis® and Beyfortus®which are monoclonal antibodies, offered to newborns in the form of injections, are available again this year:
Beyfortus®, made available in France for the first time last year, is intended for infants under one year of age, including newborns. Last year, the Beyfortus® immunization campaign showed very positive signs with parental compliance of over 80%, and prevented 5,800 hospitalizations for RSV bronchiolitis according to modeling work by Santé publique France and the Pasteur Institute. This year, twice as many doses will be available (in hospital and for the first time in pharmacies). Synagis®, for its part, is indicated for certain premature infants and for high-risk infants (in children with a heart or lung malformation, depending on the advice of the specialists who follow them).
“I avoid bronchiolitis”: a national information campaign to raise awareness among the general public
In order to widely disseminate these prevention messages and to raise awareness among parents about ways to prevent bronchiolitis, the Ministry of Labor, Health and Solidarity is launching today a national digital information campaign.
Information kits, developed in partnership with Santé publique France, will also be made available to health and early childhood professionals, who can order them via this link: _Infant_bronchiolitis_Health_authorities_launch_national_prevention_campaign_for_Bronchiolitis_I_avoid_it_[Affiche_40x60cm]_santepubliquefrance.fr’,’actionmode’, ”, ‘actionlabel’, ‘external,content,link,,custom_event’,’actionpname’, ‘component_label’, ‘actionpvalue’, ‘La bronchiolite, je l’évite [Affiche 40x60cm] santepubliquefrance.fr’,’actionpname’, ‘component_value’, ‘actionpvalue’, ‘ ‘component_hierarchy’, ‘actionpvalue’, ‘content’,’actionpname’, ‘heading_hierarchy’, ‘actionpvalue’, ‘>_Infant_bronchiolitis_health_authorities_launch_national_prevention_campaign_for>_I_avoid_bronchiolitis_[Affiche_40x60cm]_santepubliquefrance.fr’])” class=”spip_out” rel=”external”>I avoid bronchiolitis [Affiche 40x60cm] (santepubliquefrance.fr)
For more information:
Contact presse :
Directorate General of Health:
Mail : [email protected]
Tel: 01 87 05 92 12
Summary table of the terms relating to treatments
Preventive measures against bronchiolitis in infants
1726733832
#Infant #Bronchiolitis #Health #Authorities #Launch #National #Prevention #Campaign #Winter #Season
Websites.
Table of Contents
Protecting Infants from Respiratory Syncytial Virus (RSV) and Bronchiolitis: A National Public Health Priority
As the winter season approaches, the Ministry of Labor, Health and Solidarity is launching a comprehensive campaign to protect infants from respiratory syncytial virus (RSV) and bronchiolitis. RSV is the primary cause of bronchiolitis, a respiratory disease that affects approximately 30% of children under two years of age each winter. Although mostly benign, bronchiolitis can lead to serious complications in infants and remains one of the leading causes of hospitalization in children under one year of age during the winter season.
The Importance of Prevention
Preventing bronchiolitis is an essential public health priority. The health authorities are increasing parents’ awareness of the causes, symptoms, and contagiousness of this infection, and informing them of simple actions and preventive measures available to protect themselves against it. By taking daily preventive measures, parents and caregivers can limit the transmission of RSV and thus prevent bronchiolitis in young children.
Simple Actions to Take Every Day
To protect little ones, parents and caregivers can take the following simple actions:
Wash your hands before and after each change, feeding, meal, or cuddle
Ventilate the entire home regularly
Wear a mask if you have a cold, cough, or fever
Avoid taking your child to confined public places, such as supermarkets, restaurants, and public transport
Do not share bottles, pacifiers, or unwashed cutlery
Do not smoke near babies and children
Effective Preventive Treatments
In addition to these simple actions, the Ministry of Labor, Health and Solidarity is also promoting two alternative strategies to prevent bronchiolitis: maternal vaccination with Abrysvo® vaccine and infant immunization with monoclonal antibodies, such as Synagis® and Beyfortus®.
Maternal Vaccination with Abrysvo® Vaccine: This vaccination solution allows parents to choose a strategy that relies on an injection to the mother during her pregnancy, and not to the newborn. Injected between the end of the seventh month and the end of the eighth month of pregnancy, the Abrysvo® vaccine allows the pregnant woman to produce antibodies that she transmits to her child through the placenta. Thanks to this vaccination of the mother, the infant is protected from birth and up to the age of 6 months against RSV.
Infant Immunization with Monoclonal Antibodies: The two preventive treatments, Synagis® and Beyfortus®, are monoclonal antibodies offered to newborns in the form of injections. Beyfortus®, made available in France for the first time last year, is intended for infants under one year of age, including newborns. Synagis®, on the other hand, is indicated for certain premature infants and for high-risk infants (in children with a heart or lung malformation, depending on the advice of the specialists who follow them).
National Information Campaign: “I Avoid Bronchiolitis”
To widely disseminate these prevention messages and raise awareness among parents about ways to prevent bronchiolitis, the Ministry of Labor, Health and Solidarity is launching a national digital information campaign. Information kits, developed in partnership with Santé publique France, will also be made available to health and early childhood professionals, who can order them via the following
What are the best practices for preventing Respiratory Syncytial Virus (RSV) in infants?
Protecting Infants from Respiratory Syncytial Virus (RSV): A Comprehensive Guide
As the winter season approaches, it’s essential to take measures to protect infants from Respiratory Syncytial Virus (RSV), the primary cause of bronchiolitis. The French Ministry of Labor, Health, and Solidarity has launched the “Bronchiolitis, I avoid it” program to raise awareness among parents about existing prevention methods, simple actions, and preventive treatments to safeguard their baby against this winter virus.
What is Acute Bronchiolitis?
Acute bronchiolitis is a respiratory disease caused by RSV, which affects the small bronchi of infants. The signs and symptoms include coughing, rapid, and wheezing breathing. It’s estimated that 30% of children under two years old are affected during the epidemic season from October to March. Although mostly benign, bronchiolitis can lead to serious complications in infants and remains one of the leading causes of hospitalization in children under one year old during the winter season.
Prevention is Key
The prevention of bronchiolitis is an essential public health priority. Simple daily actions can help limit the transmission of RSV and prevent bronchiolitis in young children. These include:
Washing hands before and after each change, feeding, meal, or cuddle
Ventilating the entire home regularly
Wearing a mask if you have a cold, cough, or fever
Avoiding taking your child to confined public places, such as supermarkets, restaurants, and public transport
Not sharing bottles, pacifiers, or unwashed cutlery
Not smoking near babies and children
Effective Preventive Treatments
In addition to these daily actions, two alternative strategies are available to protect infants from RSV:
- Maternal Vaccination: Vaccination with Abrysvo® vaccine during pregnancy allows the pregnant woman to produce antibodies that she transmits to her child through the placenta. This provides protection to the infant from birth up to 6 months against RSV.
- Infant Immunization with Monoclonal Antibodies: Two preventive treatments, Synagis® and Beyfortus®, are available in the form of injections for newborns. Beyfortus® is intended for infants under one year of age, including newborns, while Synagis® is indicated for certain premature infants and high-risk infants.
National Information Campaign
To disseminate these prevention messages and raise awareness among parents, the Ministry of Labor, Health, and Solidarity has launched a national digital information campaign. Information kits will also be made available to health and early childhood professionals to support the campaign.
Conclusion
Protecting infants from RSV and bronchiolitis requires a proactive approach. By following simple daily actions and taking advantage of effective preventive treatments, parents can significantly reduce the risk of their child contracting this winter virus. Stay informed, stay vigilant, and let’s work together to keep our little ones safe and healthy this winter.
Keywords: Respiratory Syncytial Virus, RSV, Bronchiolitis, Infant Health, Winter Virus, Prevention, Maternal Vaccination, Infant Immunization, Monoclonal Antibodies, Abrysvo, Synagis, Beyfortus, National Information Campaign.
Note: The article is optimized for search engines with keywords and phrases relevant to the topic. The structure and content are designed to provide a comprehensive guide to protecting infants from RSV and bronchiolitis, while also highlighting the importance of prevention and awareness.
